Details on the US Food and Drug Administration’s (FDA) plans for launching a pilot project on model-informed drug development (MIDD) began trickling out on Monday with a Federal Register notice.

The European Medicines Agency (EMA) is planning to issue a draft guideline on the reporting and evaluation of new mechanistic models to encourage their broader use in model informed drug development ...